CSOWM Practice Questions and Answers – Commission on Dietetic Registration (2026/2027)

CSOWM Practice Questions and Answers –

Commission on Dietetic Registration (2026/2027)




Management of BMI >/= 25 - ANSWER-Diet, Exercise,

Behavior




Management of BMI >/= 27 + comorbidity - ANSWER-Diet,

exercise, behavior + pharmacotherapy




Management of BMI >/=35 + cormorbidity - ANSWER-

Bariatric surgery




Management of BMI >/=40 - ANSWER-Bariatric surgery

,Management of BMI >/=30 - ANSWER-Diet, exercise,

behavior + pharmacotherapy




Co-morbidities - ANSWER-T2DM

HTN

OSA and other respiratory disorders

NAFLD

OA

lipid abnormalities

gastrointestinal disorders

heart disease




Medication assessment - ANSWER-Every month x3

months, then every 3 months

,Effective weight loss % - ANSWER->/=5% in 3 months




Avoid these wt loss meds with HTN/HD - ANSWER-

Sympathomimetics (phentermine/diethylproprion)




Avoid these wt loss medications with CVD - ANSWER-

Sypathomimetics




T2DM treatment + medications to support weight loss -

ANSWER-GLP-1 analog (mitigates associated weight gain

due to insulin) or SGLT-2 inhibitors + metformin. If using

insulin, recommend basal instead of combo

, Drugs that induce weight gain - ANSWER-Tricyclic

antidepressants (Amitriptyline)

oral contraceptives (Ortho Tri-Cyclen, Yaz)

antipsychotics (Risperidone)

anticonvulsants

glucocorticoids (cortisol)

sulfonyureas- ( Glimepiride, Glipizide)

glitazones (Actos)

B-blockers (Propranolol, Metoprolol, Atenolol)




Hormonal signals for appetite - ANSWER-CCK-

duodenum

K cells- duodenum and jejunum: gatric inhibitory

polypeptide